Spots Global Cancer Trial Database for CV CARE: CardioVascular Care in PC Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: CV CARE: CardioVascular Care in PC Patients

Official Title: CV CARE: CardioVascular Care of Androgen Related Effects in Prostate Cancer Patients

Study ID: NCT06202820

Conditions

Prostate Cancer

Cardiovascular Diseases

Interventions

CV Care Program

Study Description

Brief Summary: This research is being done to test a program to assess and manage reversible cardiovascular (CV) risk factors in participants with prostate cancer starting androgen deprivation therapy (ADT), with the goal of integrating a standardized method into Dana-Farber Cancer Institute clinics for all such participants. The name of the intervention used in this research study is: CV Care (cardiovascular risk assessment and management program)

Detailed Description: This research is being done to test a program to assess and manage reversible cardiovascular (CV) risk factors in participants with prostate cancer starting androgen deprivation therapy (ADT), with the goal of integrating a standardized method into Dana-Farber Cancer Institute clinics for all such participants. Study procedures including screening for eligibility, treatment visits, questionnaires and surveys, and blood and urine tests. Participation in this research study is expected to last about 6 months. It is expected that about 60-150 people will take part in this study. This study is supported by the National Comprehensive Cancer Network (NCCN) through grant funding provided by Pfizer Myovant.